Viewing Study NCT06773156


Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-01-01 @ 4:48 PM
Study NCT ID: NCT06773156
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-01-14
First Post: 2025-01-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer
Sponsor: Second Affiliated Hospital of Nanchang University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-11-01
Start Date Type: ACTUAL
Primary Completion Date: 2028-08-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2030-08-01
Completion Date Type: ESTIMATED
First Submit Date: 2025-01-03
First Submit QC Date: None
Study First Post Date: 2025-01-14
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-01-13
Last Update Post Date: 2025-01-14
Last Update Post Date Type: ACTUAL